Germline Polymorphisms in Patients With Advanced Nonsmall Cell Lung Cancer Receiving First-Line Platinum-Gemcitabine Chemotherapy: A Prospective Clinical StudyJOERGER, Markus; BURGERS, Sjaak. A; BEIJNEN, Jos H et al.Cancer. 2012, Vol 118, Num 9, pp 2466-2475, issn 0008-543X, 10 p.Article

Relationship between Single Nucleotide Polymorphisms and Haplotypes in DPYD and Toxicity and Efficacy of Capecitabine in Advanced Colorectal CancerDEENEN, Maarten J; TOL, Jolien; SCHELLENS, Jan H. M et al.Clinical cancer research (Print). 2011, Vol 17, Num 10, pp 3455-3468, issn 1078-0432, 14 p.Article

Polymorphisms of drug-metabolizing enzymes (GST, CYP2B6 and CYP3A) affect the pharmacokinetics of thiotepa and tepaEKHART, Corine; DOODEMAN, Valerie D; RODENBUIS, Sjoerd et al.British journal of clinical pharmacology. 2009, Vol 67, Num 1, issn 0306-5251, 50-60, 145 [12 p.]Article

Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamideEKHART, Corine; DOODEMAN, Valerie D; RODENHUIS, Sjoerd et al.Pharmacogenetics and genomics (Print). 2008, Vol 18, Num 6, pp 515-523, issn 1744-6872, 9 p.Article